glp 1 receptor agonists in idiopathic intracranial hypertension and Excited to share our study @JAMANeuro GLP-1 RA therapy for GLP-1 Receptor Agonists in Idiopathic
Description
Hanna, S., Sethiadi, J., Ali, Q., & Sinha, S
Comparing "Retatrutide vs tirzepatide," evidence suggests higher efficacy with Retatrutide, yet trials are distinct
It reflects how each medication interacts with hormone pathways that influence appetite, insulin response, digestion, metabolism, and possibly energy expenditure
The FDA approved Ozempic (semaglutide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease
Marzook A, Tomas A, Jones B
